Earnings per share for the period came in at 65.1 cents for 1HFY2025.
The group says that demand for healthcare products remained resilient, and gross margin also improved from 54.6% to 56.5% due mainly to demand shifts of product segments from year to year.
For the reporting period, other income increased 20.3% to $116.8 million due mainly to higher dividend rate from strategic and long term investments.
General and administrative expenses for 1HFY2025 jumped 49.2% to $9.3 million due mainly to net foreign currency losses as compared to foreign currency gains recorded in the same period a year ago.
Finance expenses decreased 24.8% to $800,000 due mainly to lower borrowing rates in 1HFY2025.
The board of directors has proposed its first and interim dividend for 2025 of 20 cents per ordinary share.
Shares in Haw Par Corporation closed 19 cents lower or 1.327% down at $14.13 on Aug 12.